Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety & Efficacy of Eculizumab to Prevent AMR in Living Donor Kidney Transplant Recipients Requiring Desensitization
This study is currently recruiting participants.
Verified March 2013 by Alexion Pharmaceuticals
Study NCT01399593   Information provided by Alexion Pharmaceuticals

First Received on July 19, 2011.   Last Updated on March 8, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Antibody Mediated Rejection
Interventions listed in this trial
Eculizumab
Sponsors listed in this trial
Alexion Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services